Format

Send to:

Choose Destination
See comment in PubMed Commons below
Arch Intern Med. 1999 Jun 14;159(11):1248-53.

A metaregression analysis of the dose-response effect of aspirin on stroke.

Author information

  • 1Epidemiology Resources Inc, Newton Lower Falls, Mass 02162, USA. epidemiol@aol.com

Abstract

BACKGROUND:

We evaluated whether the risk of stroke depends on aspirin dose in patients with a previous transient ischemic attack or stroke.

METHODS:

We conducted a metaregression analysis of stroke by using published randomized, placebo-controlled trials. We analyzed studies of patients who had recently had a transient ischemic attack or stroke (ie, secondary prevention). We abstracted data on the treatment regimen and stroke. To evaluate the dose-response relationship, we conducted a metaregression analysis of study-specific risk ratios by means of weighted linear regression.

RESULTS:

Eleven randomized, placebo-controlled trials contributed a total of 5228 patients randomized to aspirin only and 4401 patients randomized to placebo only. The slope of the dose-response curve was virtually flat across a wide range of aspirin doses from 50 to 1500 mg/d (P = .49 for test of slope not =0). Summarizing across studies, aspirin decreases the risk of stroke by about 15% (risk ratio, 0.85;95% confidence interval, 0.77-0.94).

CONCLUSIONS:

Aspirin reduces the risk of stroke by approximately 15%, and this effect is uniform across aspirin doses from 50 to 1500 mg/d. The lowest effective aspirin dose has not yet been identified, but it could be lower than 50 mg/d.

Comment in

  • ACP J Club. 2000 Jan-Feb;132(1):9.
PMID:
10371234
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk